Index | Gene Name Primary | Protein Name | Uniprot ID | Gene Name Synonym | Ligand Name | Structure | PDB Code | ligand desolvation | Ligand Structure | Compound Affinity nM |
1 | AK1BA | Aldo-keto reductase family 1 member B10 | O60218 | AKR1B11 | uv8 | Crystal structure of human AKR1B10 complexed with NADP+ and the synthetic retinoid UVI2008 | 5m2f | 83.68 | | no data |
2 | AK1BA | Aldo-keto reductase family 1 member B10 | O60218 | AKR1B11 | mk4 | Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK184 | 5lix | 94.07 | | no data |
3 | AK1BA | Aldo-keto reductase family 1 member B10 | O60218 | AKR1B11 | fid | Human AKR1B10 mutant V301L complexed with NADP+ and fidarestat | 4gab | 87.42 | | no data |
4 | AK1BA | Aldo-keto reductase family 1 member B10 | O60218 | AKR1B11 | flf | Crystal Structure Of AKR1B10 Complexed With NADP+ And Flufenamic acid | 4i5x | 88.03 | | no data |
5 | AK1BA | Aldo-keto reductase family 1 member B10 | O60218 | AKR1B11 | tol | Crystal Structure Of AKR1B10 Complexed With NADP+ And Tolrestat | 1zua | 90.89 | | no data |
6 | AK1BA | Aldo-keto reductase family 1 member B10 | O60218 | AKR1B11 | 388 | Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor IDD388 | 5liu | 87.57 | | no data |
7 | AK1BA | Aldo-keto reductase family 1 member B10 | O60218 | AKR1B11 | suz | Crystal structure of human AKR1B10 complexed with NADP+ and sulindac | 4wev | 84.24 | | no data |
8 | AK1BA | Aldo-keto reductase family 1 member B10 | O60218 | AKR1B11 | zst | Crystal Structure Of AKR1B10 Complexed With NADP+ And Zopolrestat | 4jii | 91.02 | | no data |
9 | AK1BA | Aldo-keto reductase family 1 member B10 | O60218 | AKR1B11 | w8x | Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK181 | 5lik | 87.53 | | no data |
10 | AK1BA | Aldo-keto reductase family 1 member B10 | O60218 | AKR1B11 | 1wx | Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK319 | 5liw | 98.64 | | no data |
11 | AK1BA | Aldo-keto reductase family 1 member B10 | O60218 | AKR1B11 | qap | Crystal structure of AKR1B10 complexed with NADP+ and Caffeic acid phenethyl ester | 4gq0 | 84.87 | | no data |
12 | AK1BA | Aldo-keto reductase family 1 member B10 | O60218 | AKR1B11 | 8ql | Crystal structure of AKR1B10 in complex with NADP+ and Androst-4-ene-3-beta-6-alpha-diol | 5y7n | 83.03 | | no data |
13 | AK1C1 | Aldo-keto reductase family 1 member C1 | Q04828 | DDH DDH1 | jms | Crystal Structure of AKR1C1 complexed with meclofenamic acid | 6ijx | 97.61 | | no data |
14 | AK1C1 | Aldo-keto reductase family 1 member C1 | Q04828 | DDH DDH1 | 9s0 | AKR1C1 complexed with new inhibitor with novel scaffold | 6a7a | 94.66 | | no data |
15 | AK1C1 | Aldo-keto reductase family 1 member C1 | Q04828 | DDH DDH1 | str | Crystal structure of human 20alpha-HSD in ternary complex with NADP and 20alpha-hydroxy-progesterone | 1mrq | 81.97 | | no data |
16 | AK1C1 | Aldo-keto reductase family 1 member C1 | Q04828 | DDH DDH1 | 5p3 | Crystal structure of AKR1C1 in complex with NADP and 5-Phenyl,3-chlorosalicylic acid | 3nty | 99.22 | | no data |
17 | AK1C1 | Aldo-keto reductase family 1 member C1 | Q04828 | DDH DDH1 | gbm | Crystal Structure of AKR1C1 complexed with glibenclamide | 4yvp | 76.12 | | no data |
18 | AK1C2 | Aldo-keto reductase family 1 member C2 | P52895 | DDH2 | iu5 | Crystal Structure of Human Type III 3-alpha-Hydroxysteroid Dehydrogenase/Bile Acid Binding Protein (AKR1C2) Complexed with NADP+ and Ursodeoxycholate | 1ihi | 72.56 | | no data |
19 | AK1C2 | Aldo-keto reductase family 1 member C2 | P52895 | DDH2 | 5sd | Crystal structure of human 3-alpha hydroxysteroid dehydrogenase type 3 in complex with NADP+, 5alpha-androstan-3,17-dione and (3beta, 5alpha)-3-hydroxyandrostan-17-one | 4xo6 | 79.86 | | no data |
20 | AK1C2 | Aldo-keto reductase family 1 member C2 | P52895 | DDH2 | aox | Crystal structure of human 3-alpha hydroxysteroid dehydrogenase type 3 in complex with NADP+, 5alpha-androstan-3,17-dione and (3beta, 5alpha)-3-hydroxyandrostan-17-one | 4xo6 | 77.19 | | no data |
21 | AK1C2 | Aldo-keto reductase family 1 member C2 | P52895 | DDH2 | str | Crystal Structuer of Human 3-alpha Hydroxysteroid Dehydrogenase Type 3 in Complex with NADP+ and Progesterone | 4l1w | 76.63 | | no data |
22 | AK1C2 | Aldo-keto reductase family 1 member C2 | P52895 | DDH2 | str | Crystal Structuer of Human 3-alpha Hydroxysteroid Dehydrogenase Type 3 V54L Mutant in Complex with NADP+ and Progesterone | 4l1x | 77.61 | | no data |
23 | AK1C2 | Aldo-keto reductase family 1 member C2 | P52895 | DDH2 | ffa | Crystal structure of h3alpha-hydroxysteroid dehydrogenase type 3 mutant Y24A in complex with NADP+ and epi-testosterone | 2ipj | 77.07 | | no data |
24 | AK1C2 | Aldo-keto reductase family 1 member C2 | P52895 | DDH2 | tes | Human 3alpha-HSD type 3 in Ternary Complex with NADP and Testosterone | 1j96 | 75.04 | | no data |
25 | AK1C2 | Aldo-keto reductase family 1 member C2 | P52895 | DDH2 | flp | AKR1C2 complex with flurbiprofen | 4jtq | 82.95 | | no data |
26 | AK1C2 | Aldo-keto reductase family 1 member C2 | P52895 | DDH2 | ibp | AKR1C2 complex with ibuprofen | 4jtr | 85.96 | | no data |
27 | AK1C2 | Aldo-keto reductase family 1 member C2 | P52895 | DDH2 | suz | AKR1C2 complex with sulindac | 4jq2 | 81.53 | | no data |
28 | AK1C2 | Aldo-keto reductase family 1 member C2 | P52895 | DDH2 | imn | AKR1C2 complex with indomethacin | 4jq4 | 87.77 | | no data |
29 | AK1C2 | Aldo-keto reductase family 1 member C2 | P52895 | DDH2 | id8 | AKR1C2 complex with mefenamic acid | 4jqa | 86.28 | | no data |
30 | AK1C2 | Aldo-keto reductase family 1 member C2 | P52895 | DDH2 | nps | AKR1C2 complex with naproxen | 4jq1 | 87.28 | | no data |
31 | AK1C2 | Aldo-keto reductase family 1 member C2 | P52895 | DDH2 | zom | AKR1C2 complex with zomepirac | 4jq3 | 78.22 | | no data |
32 | AK1C2 | Aldo-keto reductase family 1 member C2 | P52895 | DDH2 | asd | Crystal structure of human 3-alpha hydroxysteroid dehydrogenase type 3 in complex with NADP+, 5alpha-androstan-3,17-dione and (3beta, 5alpha)-3-hydroxyandrostan-17-one | 4xo7 | 81.39 | | no data |
33 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | ffw | Crystal structure of Aldo-Keto Reductase 1C3 (AKR1C3) complexed with inhibitor. | 6gxk | 96.93 | | no data |
34 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | 9s0 | AKR1C3 complexed with new inhibitor with novel scaffold | 6a7b | 91.76 | | no data |
35 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | pg2 | Structure of prostaglandin F synthase with prostaglandin D2 | 1ry0 | 87.76 | | no data |
36 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | e04 | Crystal structure of human androgenic 17beta-hydroxysteroid dehydrogenase type 5 in complexed with a potent inhibitor EM1404 | 1zq5 | 90.75 | | no data |
37 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | 15m | Crystal structure of prostaglandin F synathase containing bimatoprost | 2f38 | 90.86 | | no data |
38 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | izp | AKR1C3 complex with ibuprofen | 3r8g | 97.81 | | no data |
39 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | suz | AKR1C3 complex with sulindac | 3r7m | 79.48 | | no data |
40 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | flr | AKR1C3 complex with flurbiprofen | 3r94 | 97.95 | | no data |
41 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | npx | AKR1C3 complex with R-naproxen | 3ufy | 99.25 | | no data |
42 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | imn | AKR1C3 complex with indomethacin at pH 7.5 | 3ug8 | 96.46 | | no data |
43 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | imn | AKR1C3 complex with indomethacin at pH 6.8 | 3ugr | 99.36 | | no data |
44 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | imn | Crystal structures of prostaglandin D2 11-ketoreductase in complex with the non-steroidal anti-inflammatory drugs flufenamic acid and indomethacin | 1s2a | 98.96 | | no data |
45 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | 511 | Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP+ and 2'-desmethyl-indomethacin | 4dbw | 97.64 | | no data |
46 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | 0t0 | Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4-dihydroisoquinolin-2(1H)-yl)sulfonyl)-N-methylbenzamide (80) | 4fal | 97.89 | | no data |
47 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | 0sz | Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4-dihydroisoquinolin-2(1H)-yl)sulfonyl)benzoic acid (17) | 4fam | 98.42 | | no data |
48 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | id8 | AKR1C3 complexed with mefenamic acid | 3r43 | 97.85 | | no data |
49 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | nps | AKR1C3 complex with naproxen | 3r58 | 97.94 | | no data |
50 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | zom | AKR1C3 complex with zomepirac | 3r8h | 94.59 | | no data |
51 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | asd | Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) complexed with delta4-androstene-3,17-dione and NADP | 1xf0 | 93.98 | | no data |
52 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | jms | AKR1C3 complex with meclofenamic acid | 3r6i | 96.51 | | no data |
53 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | wdu | 17beta-HSD5 in complex with 4-chloro-N-(4-chlorobenzyl)-5-nitro-1H-pyrazole-3-carboxamide | 4wdu | 93.65 | | no data |
54 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | wdx | 17beta-HSD5 in complex with [4-(2-hydroxyethyl)piperidin-1-yl](5-methyl-1H-indol-2-yl)methanone | 4wdx | 98.05 | | no data |
55 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | wdv | 17beta-HSD5 in complex with 4-nitro-2-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}methyl)phenol | 4xvd | 96.46 | | no data |
56 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | wds | 17beta-HSD5 in complex with 3-pentyl-2-[(pyridin-2-ylmethyl)sulfanyl]-7-(pyrrolidin-1-ylcarbonyl)quinazolin-4(3H)-one | 4xve | 91.73 | | no data |
57 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | gmr | Crystal structure of AKR1C3 complexed with glimepiride | 4yvx | 87.46 | | no data |
58 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | gcz | Crystal structure of AKR1C3 complexed with glicazide | 4zfc | 81.29 | | no data |
59 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | qap | Crystal Structure of AKR1C3 complexed with CAPE | 5hnt | 90.38 | | no data |
60 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | 6ny | Crystal structure of AKR1C3 complexed with a pro-drug | 5jm5 | 60.72 | | no data |
61 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | gbm | Crystal structure of AKR1C3 complexed with glibenclamide | 4yvv | 82.59 | | no data |
62 | AK1C3 | Aldo-keto reductase family 1 member C3 | P42330 | DDH1 HSD17B5 KIAA0119 PGFS | cj2 | Potent and selective Aldo-Keto Reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a Bioisosteric Scaffold Hopping Approach to Flufenamic acid | 6f2u | 91.16 | | no data |
63 | AK1D1 | Aldo-keto reductase family 1 member D1 | P51857 | SRD5B1 | str | Crystal structure of human liver delta(4)-3-ketosteroid 5beta-reductase (akr1d1) in complex with progesterone and nadp. Resolution: 2.03 A. | 3cot | 88.28 | | no data |
64 | AK1D1 | Aldo-keto reductase family 1 member D1 | P51857 | SRD5B1 | ci2 | Crystal structure of 5beta-reductase (AKR1D1) in complex with NADP+ and 5beta-pregnan-3,20-dione | 3cav | 80.83 | | no data |
65 | AK1D1 | Aldo-keto reductase family 1 member D1 | P51857 | SRD5B1 | tes | Crystal structure of Delta(4)-3-ketosteroid 5-beta-reductase in complex with NADP and TESTOSTERONE. RESOLUTION: 1.62 A. | 3bur | 98.57 | | no data |
66 | AK1D1 | Aldo-keto reductase family 1 member D1 | P51857 | SRD5B1 | tes | Crystal structure of 5beta-reductase (AKR1D1) E120H mutant in complex with NADP+ and delta4-androstenedione | 3uzz | 87.46 | | no data |
67 | AK1D1 | Aldo-keto reductase family 1 member D1 | P51857 | SRD5B1 | bdt | Crystal structure of 5beta-reductase (AKR1D1) E120H mutant in complex with NADP+ and 5beta-dihydrotestosterone | 3uzy | 82.91 | | no data |
68 | AK1D1 | Aldo-keto reductase family 1 member D1 | P51857 | SRD5B1 | pdn | Crystal structure of human liver 5beta-reductase (AKR1D1) in complex with NADP and CORTISONE. Resolution 1.90 A. | 3cmf | 86.93 | | no data |
69 | AK1D1 | Aldo-keto reductase family 1 member D1 | P51857 | SRD5B1 | asd | Crystal structure of 5beta-reductase (AKR1D1) in complex with NADP+ and 4-androstenedione | 3cas | 97.34 | | no data |
70 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | sfi | Crystal Structure of Human Aldose Reductase complexed with Sulindac Sulfide | 3rx4 | 75.33 | | no data |
71 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | lit | Human aldose reductase complexed with nitrofuryl-oxadiazol inhibitor at 1.55 A | 2ikh | 95.83 | | no data |
72 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | itb | Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (2) | 2nvd | 79.98 | | no data |
73 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ita | Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (3) | 2nvc | 78.94 | | no data |
74 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 3t4 | Human aldose reductase in complex with a nitrile-containing IDD inhibitor | 3t42 | 91.76 | | no data |
75 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | i84 | HUMAN ALDOSE REDUCTASE COMPLEXED WITH IDD384 INHIBITOR | 1el3 | 62.74 | | no data |
76 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zes | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE INHIBITOR ZENARESTAT. | 1iei | 90.58 | | no data |
77 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | bfi | Crystal structure of human Aldose Reductase complexed with NADP and Minalrestat | 1pwl | 92.94 | | no data |
78 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | fid | Human aldose reductase double mutant S302R-C303D complexed with fidarestat. | 2pdy | 85.32 | | no data |
79 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | fid | Human aldose reductase mutant C303D complexed with fidarestat. | 2pdw | 85.31 | | no data |
80 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | fid | Human aldose reductase mutant V47I complexed with fidarestat. | 2pd9 | 85.39 | | no data |
81 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | fid | Aldose Reductase Mutant Leu 300 Pro complexed with Fidarestat | 2agt | 85.97 | | no data |
82 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | fid | Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution exceeds concentration of IDD594. | 2pev | 94.84 | | no data |
83 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | fid | FIDARESTAT BOUND TO HUMAN ALDOSE REDUCTASE | 1ef3 | 85.38 | | no data |
84 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | fid | Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution is equal to concentration of IDD594. | 2pf8 | 96.12 | | no data |
85 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | fid | Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution is less than concentration of IDD594. | 2pfh | 96.13 | | no data |
86 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | fid | Crystal structure of human Aldose Reductase complexed with NADP and Fidarestat | 1pwm | 85.11 | | no data |
87 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | id5 | Crystal structure of human aldose reductase complexed with NADP and IDD552 at ph 5 | 1t40 | 92.56 | | no data |
88 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | id5 | Crystal structure of human aldose reductase complexed with NADP and IDD552 | 1t41 | 93.84 | | no data |
89 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | fir | Crystal structure of Aldose Reductase complexed with 2R4S (Stereoisomer of Fidarestat, 2S4S) | 1x97 | 86.67 | | no data |
90 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 3na | Human aldose reductase in complex with NADP+ and the inhibitor lidorestat at 1.04 angstrom | 1z3n | 92.74 | | no data |
91 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | tol | Human aldose reductase complexed with tolrestat at 1.08 A resolution. | 2fzd | 89.92 | | no data |
92 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | tol | Human Aldose Reductase complexed with four tolrestat molecules at 1.5 A resolution. | 2fzb | 99.89 | | no data |
93 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | tol | Human aldose reductase mutant L301M complexed with tolrestat. | 2pdl | 89.63 | | no data |
94 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 393 | Human Aldose Reductase mutant T113V in complex with IDD393 crystallized in spacegroup P1 | 3mc5 | 91.35 | | no data |
95 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 393 | Human aldose reductase complexed with nitro-substituted IDD-type inhibitor | 2ikj | 91.37 | | no data |
96 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 393 | Human aldose reductase mutant S302R complexed with IDD 393. | 2pdp | 91.58 | | no data |
97 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 393 | Human aldose reductase mutant C303D complexed with IDD393. | 2pdu | 91.27 | | no data |
98 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 393 | Human aldose reductase mutant L300A complexed with IDD393. | 2pdj | 89.17 | | no data |
99 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 393 | Human aldose reductase mutant F121P complexed with IDD393. | 2pdc | 91.34 | | no data |
100 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 393 | Human aldose reductase mutant T113V complexed with IDD393 | 3m64 | 91.46 | | no data |
101 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 393 | The crystallographic structure of Aldose Reductase IDD393 complex confirms Leu300 as a specificity determinant | 2pzn | 91.27 | | no data |
102 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | q74 | Human aldose reductase complexed with IDD 740 inhibitor | 3g5e | 91.59 | | no data |
103 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ldt | Human aldose reductase mutant T113V complexed with IDD594 | 3lz5 | 91.72 | | no data |
104 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ldt | Perdeuterated alr2 in complex with idd594 | 2qxw | 91.58 | | no data |
105 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ldt | Human Aldose Reductase structure | 2r24 | 93.38 | | no data |
106 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ldt | Human Aldose Reductase mutant T113A complexed with IDD 594 | 3lql | 91.73 | | no data |
107 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ldt | Human aldose reductase mutant T113C complexed with IDD594 | 3lbo | 91.56 | | no data |
108 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ldt | Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution exceeds concentration of IDD594. | 2pev | 94.7 | | no data |
109 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ldt | Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effects of radiation damage on protein structure. Third stage of radiation damage. | 3ght | 91.36 | | no data |
110 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ldt | Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effects of radiation damage on protein structure. First stage of radiation damage | 3ghr | 91.32 | | no data |
111 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ldt | Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 60K | 2i17 | 91.16 | | no data |
112 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ldt | Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 15K | 2i16 | 91.36 | | no data |
113 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ldt | Human Aldose Reductase in complex with NADP+ and the inhibitor IDD594 at 0.66 Angstrom | 1us0 | 91.23 | | no data |
114 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ldt | Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effects of radiation damage on protein structure. Forth stage of radiation damage. | 3ghu | 91.49 | | no data |
115 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ldt | Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effects of radiation damage on protein structure. Second stage of radiation damage. | 3ghs | 91.24 | | no data |
116 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ldt | Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution is equal to concentration of IDD594. | 2pf8 | 93.85 | | no data |
117 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ldt | Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution is less than concentration of IDD594. | 2pfh | 94.2 | | no data |
118 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | ldt | Human aldose reductase mutant T113S complexed with IDD594 | 3ld5 | 91.82 | | no data |
119 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 388 | Human Aldose Reductase mutant T113V complexed with IDD388 | 3m4h | 91.12 | | no data |
120 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 388 | Human aldose reductase complexed with halogenated IDD-type inhibitor | 2iki | 91.14 | | no data |
121 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | doy | Novel Benzothiazepine Inhibitor in Complex with human Aldose Reductase | 3p2v | 86.52 | | no data |
122 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | suz | Aldose reductase in complex with NSAID-type inhibitor at 1.0 A resolution | 3u2c | 81.92 | | no data |
123 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | suz | Crystal Structure of Human Aldose Reductase Complexed with Sulindac | 3rx3 | 73.48 | | no data |
124 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | slo | Crystal Structure of Human Aldose Reductase Complexed with Sulindac Sulfone | 3rx2 | 73.61 | | no data |
125 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | tlt | Crystal Structure of Human Aldose Reductase Complexed with Tolmetin | 3s3g | 67.09 | | no data |
126 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | nti | Aldose reductase complexed with a nitro compound | 3v35 | 82.15 | | no data |
127 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 2x9 | Complex of Aldose Reductase with inhibitor IDD 1219 | 4gca | 94.63 | | no data |
128 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Human Aldose reductase complexed with inhibitor zopolrestat at 1.48 A(1 day soaking). | 2fz8 | 92.42 | | no data |
129 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Human aldose reductase double mutant S302R-C303D complexed with zopolrestat. | 2pdx | 92.12 | | no data |
130 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Human aldose reductase mutant L300A complexed with zopolrestat at 1.55 A. | 2pdi | 90.53 | | no data |
131 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Human aldose reductase mutant S302R complexed with zopolrestat. | 2pdm | 92.1 | | no data |
132 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Human aldose reductase mutant F121P complexed with zopolrestat. | 2pdb | 92.39 | | no data |
133 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Human aldose reductase mutant L300P complexed with zopolrestat. | 2pdf | 90.47 | | no data |
134 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Human aldose reductase mutant V47I complexed with zopolrestat | 2pd5 | 92.69 | | no data |
135 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Human Aldose Reductase complexed with inhibitor zopolrestat after 3 days soaking (3days_soaked_2) | 2duz | 91.83 | | no data |
136 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Crystal structure of human Aldose Reductase complexed with zopolrestat after 3 days soaking (3days_soaked_1) | 2dux | 92.35 | | no data |
137 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Human Aldose Reductase mutant T113S complexed with Zopolrestat | 3len | 93 | | no data |
138 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation (10days_cocryst) | 2hvo | 92.17 | | no data |
139 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation after one day (1day_cocryst) | 2hvn | 92.11 | | no data |
140 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Human Aldose Reductase complexed with inhibitor zopolrestat after three days soaking (3days_soaked_3) | 2hv5 | 92.3 | | no data |
141 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Human Aldose Reductase complexed with zopolrestat after 6 days soaking(6days_soaked_2) | 2dv0 | 92.15 | | no data |
142 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Human Aldose Reductase mutant T113V in complex with Zopolrestat | 3m0i | 92.83 | | no data |
143 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Human Aldose Reductase complexed with inhibitor zopolrestat after six days soaking. | 2fz9 | 92.26 | | no data |
144 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | zst | Human Aldose Reductase mutant T113A complexed with Zopolrestat | 3mb9 | 93.11 | | no data |
145 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | w8x | Crystal structure of human AR complexed with NADP+ and {2-[(4-bromobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid | 4lau | 91.72 | | no data |
146 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 1ww | Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(4-iodobenzyl)carbamoyl]phenoxy}acetic acid | 4laz | 91.66 | | no data |
147 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | m15 | Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2-fluoro-4-iodobenzyl)carbamoyl]phenoxy}acetic acid | 4lb3 | 92.14 | | no data |
148 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 1wx | Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,3,5,6-tetrafluorobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid | 4lb4 | 92.06 | | no data |
149 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 4o9 | Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2,6-difluoro-4-iodobenzyl)carbamoyl]phenoxy}acetic acid | 4lbr | 92.33 | | no data |
150 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 4o8 | Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,6-difluorobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid | 4lbs | 92.13 | | no data |
151 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 2wr | Human Aldose Reductase complexed with a ligand with an IDD structure (2-(2-carbamoyl-5-fluoro-phenoxy)acetic acid) at 1.14 A | 4puu | 84.17 | | no data |
152 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 2wq | Human Aldose Reductase complexed with a ligand with an IDD structure (2-[5-fluoro-2-(prop-2-ynylcarbamoyl)phenoxy]acetic acid) at 1.12 A | 4puw | 84.99 | | no data |
153 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 2yz | Human Aldose Reductase complexed with a ligand with an IDD structure ([2-(benzylcarbamoyl)-5-fluorophenoxy]acetic acid) at 1.19 A | 4q7b | 91.1 | | no data |
154 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 30l | Human Aldose Reductase complexed with a ligand with an IDD structure ({5-fluoro-2-[(3-nitrobenzyl)carbamoyl]phenoxy}acetic acid) at 0.98 A | 4qbx | 91.91 | | no data |
155 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 37v | Human Aldose Reductase complexed with a ligand with an IDD structure (2-[2-(1,3-benzothiazol-2-ylmethylcarbamoyl)-5-fluoro-phenoxy]acetic acid) at 1.05 A | 4qr6 | 92.53 | | no data |
156 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | i98 | Crystal structure of human AR complexed with NADP+ and AK198 | 4qxi | 91.3 | | no data |
157 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 3uh | Human Aldose Reductase complexed with a ligand with an IDD structure at 1.20 A (1) | 4rpq | 85.98 | | no data |
158 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | 4g7 | Human Aldose Reductase complexed with a ligand with an IDD structure (2) at 1.07 A. | 4ys1 | 68.52 | | no data |
159 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | av5 | Crystal structure of human AKR1B1 complexed with NADP+ and compound 37 | 5ou0 | 79.47 | | no data |
160 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | aw8 | Crystal structure of human AKR1B1 complexed with NADP+ and compound 39 | 5ouj | 75.79 | | no data |
161 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | avt | Crystal structure of human AKR1B1 complexed with NADP+ and compound 41 | 5ouk | 75.01 | | no data |
162 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | wy1 | Human Aldose Reductase in Complex with NADP+ and WY14643 in Space Group P212121 | 5ha7 | 63.91 | | no data |
163 | ALDR | Aldo-keto reductase family 1 member B1 | P15121 | ALDR1 ALR2 | lpa | Crystal Structure of Aldose Reductase complexed with Lipoic Acid | 2iqd | 81.03 | | no data |
164 | KCAB2 | Voltage-gated potassium channel subunit beta-2 | Q13303 | KCNA2B KCNK2 | pdn | Voltage-dependent K+ channel beta subunit (W121A) in complex with cortisone | 3eb3 | 55.23 | | no data |
165 | KCAB2 | Voltage-gated potassium channel subunit beta-2 | Q13303 | KCNA2B KCNK2 | pdn | Voltage-dependent K+ channel beta subunit (I211R) in complex with cortisone | 3eb4 | 61.04 | | no data |
166 | KCAB2 | Voltage-gated potassium channel subunit beta-2 | Q13303 | KCNA2B KCNK2 | pdn | Voltage-dependent K+ channel beta subunit in complex with cortisone | 3eau | 61.61 | | no data |